Registry / 2023
Retatrutide Phase 2 obesity study
Retatrutide Phase 2 obesity study — ClinicalTrials.gov (2023), cited in PeptideAgent's Retatrutide evidence record.
Open original sourceSOURCE METADATA
What this record represents.
- Publisher
- ClinicalTrials.gov
- Evidence type
- Registry
- Publication year
- 2023
- Source ID
- nct04881760
WHERE THIS IS CITED